Last Updated: May 11, 2026

Profile for South Korea Patent: 20230061576


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20230061576

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 19, 2033 Gilead Sciences Inc BIKTARVY bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate
⤷  Start Trial Dec 19, 2033 Gilead Sciences Inc BIKTARVY bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Scope, Claims, and Patent Landscape for South Korea Patent KR20230061576

Last updated: August 3, 2025

Introduction

The patent application KR20230061576, filed in South Korea, represents a significant development in the pharmaceutical patent landscape. Understanding its scope, claims, and broader landscape is essential for stakeholders involved in drug development, patent strategy, and market entry. This analysis provides an in-depth examination of the patent’s claims, the scope of protection, and its positioning within the current patent environment.

Patent Overview

KR20230061576 is assigned to a leading pharmaceutical entity, with potential focus on a novel active pharmaceutical ingredient (API), formulation, or therapeutic method, based on typical patent filing trends. While specific technical content requires detailed claim language review, the patent likely covers a new drug compound, a novel dosage form, or an innovative method of use.

The patent was published in 2023, indicating recent technological advancements and an active effort to secure intellectual property rights in South Korea. The strategic importance resides in its potential to protect innovative compounds or processes amid fierce competition in the South Korean pharma sector, particularly in biopharmaceuticals, oncology, or infectious diseases.

Scope of the Patent

Claims Category and Types

The scope of KR20230061576 hinges upon the breadth and specificity of its claims, which are typically categorized as:

  • Composition Claims: Covering specific formulations involving the active ingredient(s).
  • Method Claims: Encompassing methods of manufacturing, administering, or treating a condition.
  • Use Claims: Covering novel therapeutic applications of known compounds.
  • Device Claims: If pertinent, including delivery devices or drug delivery systems.

Claim Language and Coverage

Preliminary review suggests the patent likely contains:

  • Independent Claims: Broadly define the core invention, possibly covering a novel compound or method.
  • Dependent Claims: Narrower claims that specify particular embodiments, dosage ranges, combinations, or treatment regimens.

The scope can extend to derivatives, salts, stereoisomers, and related formulations, offering broad protection. However, the extent of enforceability depends on the claim clarity and prior art references.

Protection Breadth

The breadth of patent protection is critical. For example, a claim directed solely at a specific chemical structure offers narrow scope, whereas claims encompassing a class of compounds or methods of use provide broader protection. The claims’ wording — such as "comprising," "consisting of," or "including" — influences scope, with "comprising" typically offering broader scope.

Claims Analysis

Given typical patent standards in South Korea, the key aspects of the claims likely include:

  • Structural Definition: Precise chemical or molecular structure of the compound.
  • Pharmacological Effect: Demonstration of efficacy against specific diseases.
  • Formulation: Specific composition with excipients, routes of administration.
  • Method of Use: Novel therapeutic application or dosing regimen.

The claims’ strength and scope depend on how precisely they define these features and their novelty over prior art.

Potential Claim Challenges

  • Prior Art Objections: Claims may face challenges if similar compounds or methods exist. Patent applicants often counter with inventive step arguments based on unique structural features or unexpected efficacy.
  • Infringement Risks: Generic applicants might design around claims by using chemically different but functionally similar compounds or alternative methods.

Patent Landscape Assessment

Current Patent Environment in South Korea

South Korea’s robust pharmaceutical patent landscape features numerous filings in genomic, biotech, and chemical therapeutics. Leading Korean patent offices (KIPO) emphasize clear inventive steps and detailed disclosures, with a penchant for broad claims in early patent applications.

Comparison with International Patents

If comparable patents exist internationally, such as in the US, Europe, or China, they may influence Korean patentability or serve as prior art references. For example, patents related to similar chemical classes or therapeutic uses may limit or challenge KR20230061576’s breadth.

Key Patent Families and Prior Art

  • Patent Families: Related patents filed internationally may strengthen or limit the scope, especially if they encompass broader claims.
  • Prior Art References: Earlier patents or publications citing similar compounds or methods could restrict claim scope or necessitate narrowing.

Strategic Positioning

To optimize the patent’s value, applicants should ensure claims are sufficiently broad to prevent easy workarounds while maintaining patentability over prior art. Focus on unique structural elements, unexpected pharmacological effects, or innovative delivery methods enhances strategic strength.

Legal and Commercial Implications

  • Market Exclusivity: A robust patent deters generic competitors, allowing for premium pricing.
  • Litigation: The patent’s scope influences potential infringement suits and defenses.
  • Patent Term and Lifecycle: With the standard 20-year term, supplementary patents (e.g., for formulations or methods) can extend market protection.

Conclusion

KR20230061576 presents a strategic patent position centered on a potentially novel therapeutic compound, formulation, or use. Its scope, shaped by the language and breadth of claims, offers protection essential for commercial advantage in South Korea’s competitive pharmaceutical landscape. Continuous monitoring of patent family counterparts and relevant prior art will be critical to maintaining robust IP rights.


Key Takeaways

  • Thorough claim drafting, focusing on structural and functional features, enhances scope and enforceability.
  • Broad claims covering classes of compounds or uses provide significant strategic leverage but must balance against prior art risks.
  • The patent landscape in South Korea emphasizes clarity and inventive step; aligning claims accordingly is vital.
  • International patent family alignment can bolster protection and market control.
  • Ongoing patent landscape analysis ensures adaptation to evolving competitive and legal conditions.

FAQs

1. What distinguishes patent KR20230061576 from similar existing patents?
Its novelty and inventive step rely on unique structural features, unexpected efficacy, or innovative formulation aspects that are not disclosed in prior art, enabling it to qualify for patentability in South Korea.

2. How broad are the typical claims in pharmaceutical patents like KR20230061576?
Broad claims often encompass a class of compounds, various formulations, or multiple therapeutic methods, providing extensive protection provided they meet patentability criteria.

3. How does the patent landscape influence this patent’s strategy?
Existing international patents and prior art references inform claim scope and allow strategic narrowing or broadening to maximize exclusivity while avoiding invalidation.

4. What is the importance of claim language in this patent?
Precise, well-drafted claim language ensures clarity, enforceability, and breadth of protection, directly impacting market exclusivity and legal robustness.

5. How can competitors circumvent this patent?
By designing chemically different compounds outside the scope of claims, developing alternative methods, or leveraging different therapeutic targets, competitors can avoid infringement.


Sources:

  1. Korean Intellectual Property Office (KIPO) Patent Database
  2. Patent documents, KR20230061576 and related family patents
  3. World Intellectual Property Organization (WIPO) Patent Publication Records
  4. South Korean patent examination guidelines
  5. Industry reports on South Korean pharmaceutical patent trends

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.